Warehouse REIT - The Company will invest in a diversified portfolio of UK warehouse assets located in urban areas. The Company is targeting a dividend yield of 5.5p equivalent to a yield of 5.5 per cent. for the year ending 31 March 2019. Issue price 100p. Raising up to £150m. | Destiny Pharma—A clinical stage biotechnology company - lead asset (XF-73) targets antibiotic-resistant bacterial infections in hospitals. Offer TBA. Due early September. | Avingtrans (AVG.L) Sch1 on its Reverse Takeover ....
22 Aug 2017
Small Cap Breakfast
Sareum Holdings plc (SAR:LON), 11.0 | OptiBiotix Health PLC (OPTI:LON), 20.5 | BOS Global (BOS:LON), 0 | Empresaria Group plc (EMR:LON), 36.5 | Ortac Resources (OTC:LON), 0 | Haydale Graphene Industries Plc (HAYD:LON), 0.5 | Bushveld Minerals Limited (BMN:LON), 1.2 | Zephyr Energy PLC (ZPHR:LON), 4.4
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Breakfast
Sareum Holdings plc (SAR:LON), 11.0 | OptiBiotix Health PLC (OPTI:LON), 20.5 | BOS Global (BOS:LON), 0 | Empresaria Group plc (EMR:LON), 36.5 | Ortac Resources (OTC:LON), 0 | Haydale Graphene Industries Plc (HAYD:LON), 0.5 | Bushveld Minerals Limited (BMN:LON), 1.2 | Zephyr Energy PLC (ZPHR:LON), 4.4
- Published:
22 Aug 2017 -
Author:
Derren Nathan - Pages:
Warehouse REIT - The Company will invest in a diversified portfolio of UK warehouse assets located in urban areas. The Company is targeting a dividend yield of 5.5p equivalent to a yield of 5.5 per cent. for the year ending 31 March 2019. Issue price 100p. Raising up to £150m. | Destiny Pharma—A clinical stage biotechnology company - lead asset (XF-73) targets antibiotic-resistant bacterial infections in hospitals. Offer TBA. Due early September. | Avingtrans (AVG.L) Sch1 on its Reverse Takeover ....